In a systematic review of KMT2D involvement in the pathogenesis of head and neck cancer, Santos et al. found the gene’s involvement in cell cycle inhibitors leads to the accumulation of DNA damage and the tumor’s aggressive advancement [23]. The gene discussed is KMT2D; the disease is head and neck cancer.